These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

679 related items for PubMed ID: 23024125

  • 1. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P, Ceciliano A, Millan N, Taich P, Villasante F, Fandino AC, Dominguez J, Chantada GL.
    Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
    [Abstract] [Full Text] [Related]

  • 2. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [Abstract] [Full Text] [Related]

  • 3. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL, Say EA, Pointdujour-Lim R, Cao C, Jabbour PM, Shields JA.
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [Abstract] [Full Text] [Related]

  • 4. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP, Honavar SG, Reddy VA, Khanna R.
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [Abstract] [Full Text] [Related]

  • 5. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 6. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, Jabbour P, Shields JA.
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [Abstract] [Full Text] [Related]

  • 7. Feasibility and results of an intraarterial chemotherapy program for the conservative treatment of retinoblastoma in Argentina.
    Funes S, Sampor C, Villasante F, Fandiño A, Manzitti J, Sgroi M, Neira P, Peralta L, Lagomarsino E, Schaiquevich P, Ceciliano A, Chantada GL.
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27086. PubMed ID: 29693791
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacokinetics of intra-arterial melphalan and topotecan combination in patients with retinoblastoma.
    Taich P, Ceciliano A, Buitrago E, Sampor C, Fandino A, Villasante F, Lucena E, Romero L, Chantada GL, Schaiquevich P.
    Ophthalmology; 2014 Apr; 121(4):889-97. PubMed ID: 24359624
    [Abstract] [Full Text] [Related]

  • 9. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F, Shields CL, Ghadimi H, Khodabandeh A, Roohipoor R.
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [Abstract] [Full Text] [Related]

  • 10. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, Griffin GC, Shields JA.
    Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
    [Abstract] [Full Text] [Related]

  • 11. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
    Shields CL, Kaliki S, Al-Dahmash S, Rojanaporn D, Leahey A, Griffin G, Jabbour P, Shields JA.
    Retina; 2013 Jan; 33(10):2103-9. PubMed ID: 23873161
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
    Suzuki S, Yamane T, Mohri M, Kaneko A.
    Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012
    [Abstract] [Full Text] [Related]

  • 16. Ophthalmic vasculature alterations following systemic chemotherapy and periocular Carboplatin treatment of advanced retinoblastoma.
    Piña Y, Boutrid H, Murray TG, Wolfe SQ, Schefler AC, Houston SK, Moftakhar R, Fernandes CE, Reichbach J, Aziz HA, Markoe AM, Aziz-Sultan MA.
    J Pediatr Ophthalmol Strabismus; 2010 Sep 22; 47 Online():e1-5. PubMed ID: 20886809
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP.
    Ophthalmology; 2008 Aug 22; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [Abstract] [Full Text] [Related]

  • 20. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
    Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH.
    Arch Ophthalmol; 2011 Jun 22; 129(6):732-7. PubMed ID: 21320950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.